CUSIP 92332V107COMVTYXUSDQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
138 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Affinity Asset Advisors, LLC | 6.48M | $58.56M | +2.56M | Added |
| 2 | Morgan Stanley | 4.29M | $38.77M | +4.05M | Added |
| 3 | Vanguard Group Inc | 3.94M | $35.61M | +173.6K | Added |
| 4 | Blackrock, Inc. | 3.14M | $28.38M |
| Added |
| 5 | Tang Capital Management LLC | 2.81M | $25.41M | −286.0K | Reduced |
| 6 | Baker Bros. Advisors LP | 2.35M | $21.21M | +1.33M | Added |
| 7 | Braidwell LP | 1.92M | $17.34M | +1.92M | New |
| 8 | D. E. Shaw & Co., Inc. | 1.67M | $15.04M | +1.14M | Added |
| 9 | Mpm Bioimpact LLC | 1.64M | $14.80M | +1.64M | New |
| 10 | Citadel Advisors LLC | 1.56M | $14.12M | −316.4K | Reduced |
See every fund holding Ventyx Biosciences Inc, with full quarter-over-quarter share changes.
Unlock all holders